3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Rectal Neoplasms
139
Esophageal Neoplasms
125
Pancreatic Neoplasms
96
Esophageal Squamous Cell Carcinoma
84
Colorectal Neoplasms
66
Adenocarcinoma Of Esophagus
53
Stomach Neoplasms
40
Carcinoma, Hepatocellular
40
Colonic Neoplasms
19
Anus Neoplasms
18
Neoplasms
14
Liver Neoplasms
12
Cholangiocarcinoma
10
Adenocarcinoma
8
Carcinoma, Squamous Cell
7
Bile Duct Neoplasms
7
Anal Canal Carcinoma
7
Head and Neck Neoplasms
6
Breast Neoplasms
6
Brain Neoplasms
6
Prostatic Neoplasms
5
Neoplasm Metastasis
5
Melanoma
5
Lung Neoplasms
5
Gastrointestinal Neoplasms
5
Gallbladder Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Uterine Cervical Neoplasms
4
Sarcoma
4
Vulvar Neoplasms
3
Interventions
Irinotecan
6
Gemcitabine
5
130-nm albumin-bound paclitaxel
5
Oxaliplatin
4
Fluorouracil
4
Capecitabine
4
Bevacizumab
4
Albumin-Bound Paclitaxel
4
napabucasin
3
Ocoxin
3
Leucovorin
3
pembrolizumab
2
Sorafenib
2
Paclitaxel
2
Nivolumab
2
Drug Therapy
2
Cyclophosphamide
2
Colonoscopy
2
Cetuximab
2
Aspirin
2
Ascorbic Acid
2
trifluridine tipiracil drug combination
1
trametinib
1
pralsetinib
1
penpulimab
1
lutetium Lu 177 dotatate
1
linifanib
1
halofantrine
1
guadecitabine
1
golotimod
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Digestive System Diseases
×
Radiotherapy
×
Gastrointestinal
×
Clear all
NCT02241499
2020-02-28
PALAESTRA
Lund University Hospital
Phase 2
Completed
29 enrolled